Beals-Hecht syndrome and choroidal neovascularization

被引：0

作者：

Gallego-Pinazo, Roberto ^{[1
]}

Lopez-Lizcano, Ruth ^{[1
]}

Millan, Jose Maria ^{[2
,3
]}

Arevalo, J. Fernando ^{[5
]}

Mullor, J. Luis ^{[6
]}

Diaz-Llopis, Manuel ^{[1
,3
,4
]}

机构：

[1] Hosp Univ La Fe, Dept Ophthalmol, Av Campanar 21, Valencia 46009, Spain

[2] Hosp Univ La Fe, Unit Expt Opthalmol, Dept Genet, Valencia, Spain

[3] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Valencia, Spain

[4] Univ Valencia, Fac Med, Valencia, Spain

[5] Clin Oftalmol Ctr Caracas, Retina & Vitreous Serv, Caracas, Venezuela

[6] Hosp La Fe, Unit Expt Opthalmol, Fdn Parala Invest, Valencia, Spain

来源：

CLINICAL OPHTHALMOLOGY | 2010年 / 4卷

关键词：

Beals-Hecht syndrome; connective tissue disease; choroidal neovascularization; ranibizumab;

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Purpose: To describe a case of choroidal neovascularization (CNV) in a female diagnosed with Beals-Hecht syndrome. Methods: A retrospective, interventional case is described in a 26-year-old female complaining of metamorphopsia and visual loss in her left eye (counting fingers). The fluorescein angiogram and the optical coherence tomography supported the diagnosis of CNV. Intravitreal ranibizumab was administered. Results: After the third intravitreal ranibizumab, her visual acuity improved to 0.8 and the morphology of the macular area was restored. Conclusions: To our knowledge this is the first report of CNV in Beals-Hecht syndrome treated with ranibizumab. Self-monitoring by periodically performing Amsler grid test is strongly recommended in these patients in order to achieve an early diagnosis of eventual CNV and avoid visual acuity loss.

引用

页码：845 / 847

页数：3

共 50 条

[21] Treatment of Choroidal Neovascularization in High Myopia
Montero, Javier A.
Ruiz-Moreno, Jose M.
CURRENT DRUG TARGETS, 2010, 11 (05) : 630 - 644
[22] Intravitreal ranibizumab in a patient with choroidal neovascularization secondary to multiple evanescent white dot syndrome
Rouvas, A. A.
Ladas, I. D.
Papakostas, T. D.
Moschos, M. M.
Vergados, I.
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (06) : 996 - 999
[23] Choroidal Neovascularization Associated with Multiple Evanescent White Dot Syndrome Treated with Intravitreal Ranibizumab
Parodi, Maurizio Battaglia
Iacono, Pierluigi
Zucchiatti, Ilaria
Bandello, Francesco
OCULAR IMMUNOLOGY AND INFLAMMATION, 2018, 26 (04) : 608 - 611
[24] Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularization Secondary to Morning Glory Syndrome in a Child
Ozkaya, Abdullah
Yilmaz, Ihsan
Karakucuk, Yalcin
Alkin, Zeynep
Yazici, Ahmet Taylan
OPHTHALMOLOGICA, 2014, 232 : 47 - 47
[25] Treatment of traumatic choroidal neovascularization with ranibizumab
Janknecht, P.
OPHTHALMOLOGE, 2011, 108 (01): : 57 - 59
[26] Inflammatory choroidal neovascularization
Neri, Piergiorgio
Lettieri, Marta
Fortuna, Cinzia
Manoni, Mara
Giovannini, Alfonso
MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY, 2009, 16 (04) : 245 - 251
[27] Iatrogenic choroidal neovascularization
Lim, JI
SURVEY OF OPHTHALMOLOGY, 1999, 44 (02) : 95 - 111
[28] Choroidal neovascularization in a patient after resolution of multiple evanescent white dot syndrome: A case report
Burova, Marie
Stepanov, Alexandr
Almesmary, Basma
Jiraskova, Nada
CLINICAL CASE REPORTS, 2022, 10 (05):
[29] Multimodal imaging in differential diagnosis between papilledema and choroidal neovascularization associated with morning glory syndrome
Cennamo, Gilda
Montorio, Daniela
Morra, Vincenzo Brescia
Costagliola, Ciro
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2023, 33 (06) : NP100 - NP102
[30] INTRAVITREAL AFLIBERCEPT INJECTION FOR CHOROIDAL NEOVASCULARIZATION DUE TO PRESUMED OCULAR HISTOPLASMOSIS SYNDROME The HANDLE Study
Toussaint, Brian W.
Kitchens, John W.
Marcus, Dennis M.
Miller, Daniel M.
Kingdon, Megan L.
Holcomb, Diana
Ivey, Ken
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (04): : 755 - 763

← 1 2 3 4 5 →